Prime Time for Lower Extremity Artery Disease

Curr Vasc Pharmacol. 2020;18(3):201-203. doi: 10.2174/1570161117999190724145226.

Author

Marco De Carlo¹

Affiliation

¹ Cardiothoracic and Vascular Department Ospedale Cisanello, Via Paradisa 2 56124 Pisa, Italy.

PMID: 32340598
DOI: 10.2174/1570161117999190724145226

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Anticoagulants / adverse effects
Anticoagulants / therapeutic use*
Clinical Decision-Making
Endovascular Procedures* / adverse effects
Fibrinolytic Agents / adverse effects
Fibrinolytic Agents / therapeutic use*
Hemorrhage / chemically induced
Humans
Lower Extremity / blood supply*
Peripheral Arterial Disease / diagnostic imaging
Peripheral Arterial Disease / epidemiology
Peripheral Arterial Disease / therapy*
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / therapeutic use*
Risk Factors
Treatment Outcome
Vascular Surgical Procedures* / adverse effects

Substances

Anticoagulants
Fibrinolytic Agents
Platelet Aggregation Inhibitors